INTERPACE BIOSCIENCES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $22.77 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2021-04-01
- INTERPACE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $22.77M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2020-12-31 | $22.77M 10-K · filed 2021-04-01 |